Article Listing - Alpharma files to remove stay on gabapentin launch

SELF-MEDICATION IN EUROPE IN THE 1990s

23 March 1992

The criteria for success for companies marketing self-medication pharmaceutical products in Europe will change fundamentally over the next three years,...

PIERRE FABRE ON EXPANSION TRAIL

23 March 1992

The second largest independent French drugs group, Pierre Fabre, is to give priority to research and development in order to...

UK MARKETING OF MAXEPA

23 March 1992

The only prescription formulation of the fish oil-derived omega-3 fatty acid product Maxepa is to be marketed in the UK...

GENETIC IMMUNIZATION ADVANCE

23 March 1992

The new technique of genetic immunization could represent a time- and labor-saving means of eliciting antibodies and it could offer...

CUROSURF LICENSING DEAL

23 March 1992

Switzerland's Ares-Serono Group and Parma, Italy-based Chiesi Farma-ceutici have announced an agreement in which the former acquires exclusive rights to...

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

The task of pharmaceutical industry management is to achieve the best possible balance between the constant pull of the...

ARGENTINE GENERICS POLICY CHANGE

23 March 1992

Having established at the beginning of 1992 a generics policy which required doctors to prescribe medicines using generic names only,...

CHILE COMPLETES ITS PATENT LAWS REFORMS

23 March 1992

One of the many features which differentiate the Chilean pharmaceutical sector from that of other Latin American countries is that...

US FDA "SHOULD BAN SPEAKER LISTS"

23 March 1992

Among the views presented to the US Food and Drug Administra-tion on its proposed draft guideline on Drug Company-Sponsored Activities...

US PRESCRIPTION PRICES UP 8.1%IN 1991

23 March 1992

Prescription prices in the USA increased by 8.1% last year to an average of $14.75 at pharmacy acquisition prices, compared...

Showing 94591-94600 of 95376 articles